Table 1.

Ambulatory Care Quality Measures: Criteria and Number of Eligible Patients at Baseline

Quality measure	Numerator criteria	Denominator criteria	Number eligible*
Chronic disease process of care measures
Antiplatelet drug prescribed for patients   with coronary heart disease	Antiplatelet drug on medication list	Diagnosis of coronary  heart disease	920
Lipid-lowering drug prescribed for   patients with coronary heart disease	Lipid-lowering drug on medication list†	Diagnosis of coronary  heart disease	948
Beta-blocker prescribed for patients   with history of myocardial infarction	Beta-blocker on medication list	History of myocardial infarction	168
ACEI or ARB prescribed for patients with   coronary heart disease and diabetes	ACEI or ARB on medication list	Diagnosis of coronary heart  disease and diabetes mellitus	272
Anticoagulant prescribed for patients   with atrial fibrillation and heart failure	Anticoagulant on medication list	Diagnosis of heart failure  and atrial fibrillation	107
ACEI or ARB prescribed for patients   with heart failure with LVSD	ACEI or ARB on medication list	Diagnosis of heart failure‡	245
Beta-blocker prescribed for patients   with heart failure with LVSD	Beta-blocker on medication list	Diagnosis of heart failure‡	242
Screening or treatment for   diabetic nephropathy	Urine microalbumin test within 1 year§	Diagnosis of diabetes mellitus	1,348
Intermediate outcome measures
Blood pressure control for patients   with hypertension	Most recent blood pressure or mean  blood pressure ≤140/90║	Diagnosis of hypertension¶	2,914
Glycemic control for patients   with diabetes	Hemoglobin A1C <8.0% within 1 year	Diagnosis of diabetes mellitus	1,348
Blood pressure control for patients   with diabetes	Most recent blood pressure or mean  blood pressure ≤130/80║	Diagnosis of diabetes mellitus	934
LDL control for patients with diabetes	LDL <100 mg/dl (<2.6 mmol/l) within 1 year#	Diagnosis of diabetes mellitus**	1,146
Preventive care measures
Pneumococcal immunization	Pneumococcal vaccine ever administered	Age ≥65	2,246
Osteoporosis screening or treatment	Bone density test completed at or after age 60††	Women age ≥65	1,451
Colorectal cancer screening	FOBT within 1 year, sigmoidoscopy or DCBE  within 5 years, or colonoscopy within 10 years	Age 50–80	5,294
Cervical cancer screening	Cervical cytology within 3 years	Women ages 21–64	4,769
Breast cancer screening	Mammography within 2 years	Women ages 50–69	2,784

^*Number of black and white patients eligible for each measure on February 1, 2008

^†Patients were considered to have an exception for this measure if they had an LDL <100 mg/dl (<2.6 mmol/l) within the past 1 year

^‡Patients were excluded from this measure if they had an ejection fraction >40%

^§Patients were also considered to have satisfied this measure if they had an ACE inhibitor or ARB on their active medication list

^║Patients were considered to have an exception for this measure if they had a diuretic medication and medications from 2 or more other antihypertensive drug classes on their active medication list

^¶Patients with diabetes were excluded from this measure

^#Patients were considered to have an exception for this measure if they had a maximum dose of a high potency statin (atorvastatin 80 mg daily, rosuvastatin 40 mg daily, or simvastatin 80 mg daily) on their active medication list

^**Women younger than 50 years were excluded from this measure

^††Patients were also considered to have satisfied this measure if they had a bisphosphonate, systemic estrogen, selective estrogen receptor modulator, parathyroid hormone, or calcitonin on their active medication list

Abbreviations: ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; LVSD, left ventricular systolic dysfunction; LDL, low-density lipoprotein cholesterol; FOBT, fecal occult blood test; DCBE, double contrast barium enema